Filing Details

Accession Number:
0001567619-22-008798
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2022-04-21 16:17:48
Reporting Period:
2021-02-18
Accepted Time:
2022-04-21 16:17:48
Original Submission Date:
2021-02-19
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1829802 Sensei Biotherapeutics Inc. SNSE () DE
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1797409 Cambrian Biopharma Inc 228 Park Avenue S.
#66643
New York NY 10003
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-02-18 752 $19.75 4,690,905 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. This Form 4 is being amended to correct the number of shares purchased. The original Form 4 filed on February 19, 2021, overstated the number of shares purchased.
  2. These shares are held by Cambrian Biopharma, Inc., a Delaware corporation ("Cambrian"). The Chief Executive Officer of Cambrian, James Peyer, may direct the voting and disposition of the shares held by Cambrian, subject in certain instances to the approval of Cambrian's Board of Directors. Mr. Peyer disclaims beneficial ownership of such shares.